Homeprophylactic migraine

  • Alder to present Phase 3 Eptinezumab results at AAN 2018

    • April 20, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Aimovig halves Migraine days in difficult to treat patients, study to be presented an AAN finds

    • April 18, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • CRLs, leading to fremanezumab launch delay in Migraine, acknowledged by Celltrion

    • April 10, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Migraine associated with Increased Heart stroke risk, says recent analysis

    • April 6, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • sTMS Device can prevent Migraine attacks, claims a recent observational study

    • April 2, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more